Netherlands· NL-7779af35c972
Iopamidol ADOH 408 mg/ml (200 mg jodium/ml), oplossing voor injectie
A iopamidol product containing jopamidol, registered in Netherlands by ADOH B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Iopamidol is registered in 12 of 19 countries.
Countries holding a registration under ATC V08AB04 (iopamidol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Iopamidol · ATC V08AB04
12 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- JOPAMIDOL
- Manufacturer
- ADOH B.V.
- Country
- Netherlands (NL)
- ATC code
- V08AB04
- ATC class
- Iopamidol
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128669
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for iopamidol.
Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iopamidol · interactions on record
367 records
- 286 severe
- 54 moderate
- 27 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V08AB04
Iopamidol, as other registers publish it.
- FranceCLEMIS 300 mg d’lode/mL, solution injectableB.E.IMAGING (ALLEMAGNE)
- FranceCLEMIS 370 mg d’lode/mL, solution injectableB.E.IMAGING (ALLEMAGNE)
- IrelandGastromiro 612.4 mg/ml oral or rectal solutionBracco Imaging spa
- United KingdomGastromiro 612.4mg/ml solution 100ml bottlesBracco UK Ltd
- United KingdomGastromiro 612.4mg/ml solution 20ml bottlesBracco UK Ltd
- United KingdomGastromiro 612.4mg/ml solution 50ml bottlesBracco UK Ltd
- United StatesiopamidolSlate Run Pharmaceuticals, LLC
- United StatesiopamidolSlate Run Pharmaceuticals, LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6b7c460-db17-47d4-a667-25bbe69dbff3 GET /v1/drugs/b6b7c460-db17-47d4-a667-25bbe69dbff3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128669_smpc.pdf",
"strength": null,
"atc_label": "Iopamidol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128669",
"excipients": [
"DINATRIUMCALCIUMEDETAAT, GEHYDRATEERD (E 385)",
"NATRIUMHYDROXIDE (E 524)",
"TROMETAMOL",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"JOPAMIDOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128669.pdf",
"authorised_at": "2022/05/18",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "128669",
"additional_monitoring": "N"
}See everything about iopamidol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.